newsfilter
← Latest News
Business Wire·

Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results

Recruitment for Phase 1/2 CEDAR clinical trial of GPH101 for sickle cell disease underway at multiple sites Details about CEDAR trial to be presented at 63rd ASH Annual Meeting and Exposition in December $395.0 million in cash, cash equivalents an